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According  to  the  World  Health  Organization’s  world  health
report  2004,  cerebral-vascular  disease  --  stroke  --  is  the  third
leading  cause  of  premature  death  in  both  genders.1 Its  great-
est  impact  is  represented  as  the leading  cause  of  disability
in  adults  and  the second  leading  cause  of  dementia.
Over  15  million  cases  of  stroke  occur  every  year  world-
wide,  one  case  every  6  s. The  impact  of  the  disease  is  greater
in  developing  countries  (2 out  of 3 cases).  In  2005,  87%  of
the  5.7  deaths  by  cerebral-vascular  disease  were  in lower
or  middle  socio-economic-level  countries.2 This  means that
by  the  year  2020,  over  52  million  deaths will  be  caused  by
strokes  in  developing  countries.3
In Mexico,  according  to  the National  Institute  of  Statis-
tics  and  Geography  (INEGI,  by  its  Spanish  acronym),  strokes
were  the  sixth  leading  cause  of death  in 2012,  just  after
heart  diseases,  diabetes  mellitus,  malign  tumors,  accidents
and  liver  diseases.4 The  fact  that it registered  as  number
6  may  seem  like  in  Mexico,  death  by  cerebral-vascular  dis-
ease  is less  frequent.  However,  it is  possible  that  when  it
occurs  in  diabetic  patients  it becomes  sub-registered.  This
can  be  explained  in different  ways.  Approximately  30%  of
patients  who  suffer  a stroke  have  comorbidities  with  other
diseases  of cardiovascular  risk,  such  as  diabetes,  heart  dis-
eases,  hypertension  and  other  modifiable  risk  factors,  which
are  registered  as  the  main  cause  of  death  in  the  certificates
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in our  country.  Another  explanation  is  the lack  of  a universal
term  that  encompasses  the  whole  spectrum  of  the  disease.
For  example,  in the US the  word ‘‘stroke’’  includes  ischemic
vascular  disease  and  hemorrhagic  vascular  disease,  and  it is
clearly  separated  from  heart  disease.  In Spain  a single  term
is  used:  ‘‘ictus’’.  This  allows  them  to  have  global  numbers
of  the  disease.  In Brazil,  it is  known  as the second  leading
cause  of  death.  On  the  other  hand,  in Mexico,  like  in many
other  countries  in  Latin America,  there  is  no  clear  distinction
between  the diseases  involving  the cardiovascular  system.
The  General  population  and  healthcare  personnel  use  many
‘‘similar’’  terms  to  refer  to  cerebral-vascular  disease,  or
stroke,  like  embolism,  apoplexy,  brain  attack,  cerebral
infarct,  cerebral  hemorrhage  and  cerebral-vascular  acci-
dent; it  is, in  many  cases,  even  generalized  as  ‘‘infarct’’,
without  specifying  whether  it  was  the heart  or  the  brain.
This  causes  a  fragmentation  in the registry  of the disease,
thus  its  incorrect  representation  in official  health  records.
Cerebral-vascular  disease  is  more  frequent  in adults  and
its  frequency  increases  significantly  after the age of  60;
however,  it  may  occur  at any age.  The  reason  for this
is  the variety  of  etiologies,  ranging  from  genetic  causes,
metabolic  origin,  hematological  causes,  cardio-embolic  ori-
gin,  atherosclerosis  and  even  some caused  by  direct  trauma
like  arterial  dissection;  thus,  age  does  not  represent  a
restriction  to  suffering  from  a  cerebral-vascular  disease.  For
example,  children  with  sickle  cell anemia  may  suffer  a cere-
bral  infarction  during  the first  years  of  their  lives;  a teenager
may  suffer  a carotid  artery  trauma  during a car  accident,
causing  a  carotid  dissection  resulting  in cerebral  infarc-
tion  by  occlusion  of  the neck  vessels.  A young  adult with
cardiovascular  risk  factors  may  suffer  a  cerebral  infarction
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secondary  to  a heart  paroxysmal  arrhythmia  caused  by  a  thy-
roid  disorder,  or  even  by a defect  in  the  electric  conduction
to  the  myocardium;  lastly,  the elderly  may  suffer  a  cerebral
infarct  caused  by  an extra  atherosclerotic  or  intracranial
plaque  which  progressively  occludes  an artery that  irrigates
the  brain.  Therefore,  it is  a  disease  which affects  all  ages,
with  multiple  etiologies,  and  one  that should  be  contem-
plated  by  the  Health  Sector  as  catastrophic  and  a  priority.
The  average  age  of  onset  of  cerebral-vascular  disease
is  65 years  of age,  and  the  prevalence  and  incidence  of
the  disease  will  hopelessly  increase  with  the demographic
change.  In  2004,  the base  of  the  population  pyramid  is  nar-
rower  than  in 1990  due  to  the fact  that  the proportion  of
children  and  young  people  had  been significantly  reduced,
with  an  increase  from  6.2  to  9.7%  in the  participation  of  the
elderly.  By  2050,  this  is  expected  to  increase  to  21.5%.5 The
increase  in  the  survival  rate  of the population  has  caused
most  deaths  to  occur  at an advanced  age.  For  example,  in
Mexico,  out  of  the  602,000 deaths  registered  in 2012, 61.9%
corresponded  to people  over  60  years  of  age  and older,  the
higher  percentage  of  mortality  reported  by  the INEGI  in  2012
was  a  result  of  chronic  degenerative  diseases,  among  which
a  few  stand  out:  diabetes  mellitus  (16.9%),  ischemic  heart
diseases  (16.5%)  and  cerebral-vascular  diseases  (7%).4
Most  of the healthcare  information  registered  in  the
country  is  based  on hospital  reports  and  death  certificates.
There  are  few  epidemiological  studies  based on  communal
studies  designed  to  determine  the prevalence  and incidence
of  cerebral-vascular  disease  in  Mexico.6
Information  on  cerebral-vascular  disease  incidence  in
Mexico  results  from  a door-to-door  study  called  BASID  (The
Brain  Attack  Surveillance  in Durango),7 where  the accumu-
lated  incidence  was  232.3  per  100,000  inhabitants  (IC 95%
27.8--436.9),  with  a mean  sample  of  51.5  years  of  age and
16%  subjects  over  65  years  of  age.
In  Latin  America,  the  variation  of  cerebral-vascular  dis-
ease  prevalence  is  wide.  In  Mexico,  estimations  suggest  6.7
per  1000  inhabitants  in  urban  areas  and  6.5  per  1000 in rural
areas.8 In the BASID  study,  cerebral-vascular  disease  preva-
lence  was  7.7  per  1000  in  all  patients  and  18.2  per  1000  in
those  60  years  old  or  older.7
Cerebral-vascular  disease  mortality  rate  has  increased  in
Mexico,  while  the mortality  rate  has  decreased  in  devel-
oped  countries,  like  in the  US,  where  it went  from  being
the third  leading  cause  of  death  to  number  4,9 This  was
thanks  to  the  education  awareness  of the population,  early
detection  of  risk  factors,  and  the implementation  of  spe-
cialty  hospital  services,  called  Stroke  Units. In  Mexico,  in  the
year  2000,  435,386  deaths  by  cerebral-vascular  disease  were
registered,  with  an annual  mortality  rate  of  25.21/100,000,
while  in  the year  2008,  538,288  deaths  were  registered
with  an  annual  mortality  rate  of  28.3/100,000.10 In  2007,
cerebral-vascular  disease  was  the  fourth  cause  of death  in
people  65  years  of age  and  older,11 and  in 2012, it  is  the third
leading  cause  of death  after diabetes  and  heart  diseases.4
Global  CVD mortality  rates reported  in  some hospital
records  in  the  country  range  from  19.6%  at 30  days  up  to
29%  at  one  year.  Cerebral  hemorrhage  reported  a  higher
mortality  rate  than  cerebral  infarction.6
The  most  commonly  associated  risk  factors  of  cerebral-
vascular  disease  in our  country  are high  blood  pressure
(65--70%),  diabetes  mellitus  (35--39%),  obesity  (50%),
frequent  consumption  of alcohol  (16%),  smoking  (16--24%)
and dyslipidemia  (11%).7,12
Cerebral-vascular  disease  (CVD)  includes  ischemic  and
hemorrhagic  CVD  and  cerebral  venous  thrombosis  (CVT).  At
the  same  time,  ischemic  CVD  includes  transient  ischemic
attack  (TIA)  and cerebral  infarction  (CI);  Hemorrhagic  CVD
includes  different  forms  of  intracranial  hemorrhage  (ICH),
such  as  cerebral  hemorrhage  (CH)  and  subarachnoid  hem-
orrhage  (SAH),  excluding  those  hemorrhages  of  traumatic
etiology.  The  most  common  form  of  cerebral-vascular  dis-
ease  is ischemic,  especially  cerebral  infarction  (≈60--80%).13
The  most frequent  ischemic  CVD  etiology  in  Mexico  can-
not  be precisely  known, due  to  the fact that  a  uniform
protocol  of attention  to  the  disease,  including  a  diagnostic
approach,  does  not exist  among  hospitals  in this coun-
try.  This  is  unfortunate  because  the  secondary  prevention
treatment,  which helps to  avoid  a  recurrence,  depends  on
the  prompt  etiological  definition  of  the cerebral  infarct.
For  example,  in the PREMIER  study,  the etiological  mech-
anism  registered  to  cerebral  infarct  was:  8% by  large  artery
atherosclerosis,  20%  by  lacunar  infarction  or  by  small  vessel
disease,  20%  by  cardioembolism,  without  specifying  whether
or  not  it was  atrial  fibrillation,  5%  by  diverse  causes  and  41%
by  an undefined  etiology.13 It is  evident  that  the etiology
of cerebral  infarction  is  defined  as  the  necessary  laboratory
and  clinical  studies  are conducted.  In the 2012  report  of
the  neurovascular  unit  of  the University  Hospital  of  Mon-
terrey,  39%  were  caused  by  large  artery  atherosclerosis,
17%  by  lacunar  infarction  or  by  small  vessel  disease,  13%
by  cardioembolism,  0.5%  by  arterial  dissection  and  24%  by
undetermined  causes.14 These  differences  are due  to  the
fact  that  the hospital  has  created  a  systematic  form  for  the
clinical  and laboratory  studies,  such  as  MRIs  (86%),  echocar-
diograms  (60%) and  ultrasound  studies  of  the arteries  of  the
neck  (75%),  during the  patient’s  stay  in the acute  stage  of
the  stroke,  while  in the PREMIER  study  (the  first  multicenter
study  in Mexico)  an  MRI  was  performed  on  24%,  an echocar-
diogram  on  15%  and  a  carotid  ultrasound  study  on  20%  of the
patients  registered  with  a  stroke.  Despite  the high  percent-
age  of  cases without  an  etiological  definition,  the rate  of
recurrence  of  cerebral  ischemia  was  8%  annually,12 and  50%
occurred  in the first  month  after the  initial  event.
The  functional  incapacity  after  an ictus  for  cerebral
vascular  event is  a consequence  of  the  extent  of the cere-
bral  damage.  For  example,  in the evolution  of  a stroke,
if  the treatment  is  begun  as  early  as  possible  and is  able
to  reestablish  cerebral  circulation  before  the first  3 h  of
the  evolution,  functional  and  neurological  recuperation  will
be  very  satisfactory.  In Mexico’s  registers,  between  24  and
59%  of  patients  are  left  with  moderate  to  severe  functional
dependency  at  30  days  of  follow-up.  The  greater  degree
of functional  damage  is  felt by  patients  in  rural  areas,  as
opposed  to urban,8,15 possibly  due  to  incomplete  medical
attention  and  the  lesser  exposure  of  new  treatments  in rural
areas.
Another  reason  why  the health  priority  that  CVD  repre-
sents  is underestimated  is  a  lack  of  complete  analysis  of
the  costs.  In  Mexico,  the  hospital  costs  are less  than  those
reported  by  other  countries  like  the United  States,  Spain
or  Brazil.  However,  the true cause  seems  to  be the greater
mortality  rate  and  the lack  of  diagnostic  approach  studies
made  in our hospitals,  causing  the lack  of  definition  of the
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etiology,  thus  the administration  of  a medication  which  is
less-effective  in  avoiding  recurrence.  On the  other  hand,
the  indirect  cost  of  a patient  with  neurological  sequelae  and
functional  dependence  is enormous,  especially  if we  con-
sider  long-term  care, rehabilitation,  the  loss  of  productive
capacity  and  the impact  on  the family  economy.
The  first  step  in the  chain  of  events  that  lets  us treat  a
patient  with a cerebral-vascular  event opportunely  is  the
recognition  of  the  alarm  symptoms  and  the necessity  of
moving  the  patient  to  a hospital  center  immediately.2 The
Mexican  population  does  not  know  the alarm  signs of a
cerebral-vascular  event.  For example,  in Mexico  City  it was
found  that  37%  of  the population  recognized  an alarm  symp-
tom  such as  weakness  in  an  arm or  leg,  deviation  of  the
mouth  or  difficulty  speaking,  but  only  2.1%  could  name  3  or
more  clinical  manifestations.  This  evidences  the  necessity  of
making  massive  education  campaigns  with  the information
that  would  permit  the population  to  identify  the manifes-
tations  of a cerebral-vascular  event  and permit  the  urgent
transportation  to  a  hospital.16,17
Current  treatment  has  changed  the  panorama  of  CVD,
especially  cerebral  infarcts.  Since  1995,  it has  been  known
that  the  treatment  called  thrombolysis  allows  patients  who
immediately  go to  a  hospital  to  receive  an intravenous  med-
ication  which  recanalize  the  occluded  artery and which  can
sometimes  achieve  a complete  recovery  in the  neurological
functions  of  the  patient.  The  time  in  which  this  medication
can  be  appiled  is  only 4-and-a-half  hours  from  the onset  of
symptoms.  Nevertheless,  its  use  has  changed  the  way  we
see  ischemic  CVD  and opened  the hope  of  medical  recu-
peration  for  the patient.  Because  of this,  it is  a  priority
to  annouce  to  the public  that  they  must  get  to  a  hospital
quickly  if they  notice  signs of  ischemic  stroke,  and  ask  the
doctors  and  authorities  to  prepare  to offer  this  alternative
treatment  in national  hospitals.
There  have  been some  efforts  made  to  improve  the
public’s  knowledge  of,  and the hospitals’  attention  to,
this  disease  in Mexico.  National  and  international  scientific
meetings  have  been organized,  generating  collaboration
initiatives  between  national  societies like  the  Mexican
Neurological  Academy  and  the  Mexican  Association  of
Cerebral-Vascular  Disease,  and  other  international  associ-
ations  like  the Iberoamerican  Society  of  Cerebrovascular
Disease,  the  American  Academy  of  Neurology  and  the World
Federation  of  Neurology.  In 2010  the  first Neurovascular
Units  were  inaugurated  in Mexico,  although,  to  this  day,  the
only  one  that  has  survived  the  passage  of time  has  been
the  one  at the University  Hospital  of  the  city  of  Monter-
rey,  thanks  to  the aid  of  the  local  authorities.  On  October
29th,  ‘‘World  Cerebral-Vascular  Disease  Day’’  in  2012,  the
state  of  Nuevo  Leon won  first  place  in  the  World Stroke  Cam-
paign  of  the  World Stroke  Organization  with  the Campaign
of  Education  and Diffusion  against  Cerebral  Attacks,  made
with  the  aid  of the  Secretary  of Health.  Other  states of
Mexico  have  added  to  the effort  of working  toward  this pro-
posal,  highlighting  the states  of Querétaro,  Sinaloa,  Jalisco,
Chiapas  and the Federal  District,  with  education  programs
and  training  for  medical  personnel  and paramedics  on  pre-
hospitalization  attention.  In the framework  of  the  Annual
Meeting  of the Mexican  Neurological  Academy  in  November
of  2013,  the  Merida  Declaration  was  made,  where  a  commit-
ment  was  signed  between  medical  societies  to  work  together
with the  states  of  Mexico  to  improve  the  means  of educa-
tion,  prevention  and  medical  and  paramedical  attention,  as
well  as  the  rehabilitation  services  of cerebral-vascular  dis-
ease.  However,  in  spite  of  all  these  efforts,  the  impact  on the
recovery  of  the patient  with  a cerebral-vascular  event  has
been  minimal.  We  believe  that  the only  way  to  change  and
improve  the prognosis  of  patients  with  a  cerebral-vascular
event  or  Stroke  is  to  guarantee  their  management  with
national  health  coverage.  We  must  develop  a  strategic  plan
for  universal  coverage  of  CVD  through  educational  programs,
organization  of  pre-hospitalization  attention,  and growth
of  the medical  infrastructure  with  the  support  of authori-
ties  and  the  Goverment,  which  will  allow  us  to  access  the
treatments  which  have  been scientifically  demonstrated  to
change  the functional  prognosis  of  the  patient.
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